483
DiAgam Societe Anonyme (S.A.)FDA 483 - DiAgam Societe Anonyme (S.A.) - December 18, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Diagam Societe Anonyme (S.A.) in Ath, Belgium, revealed significant deficiencies in their manufacturing processes for Alpha2-Macroglobulin immunoturbidimetry IVD kits. The firm failed to adequately validate critical capping processes and analyzer testing, and operated equipment outside validated parameters. Additionally, procedures for equipment maintenance, finished device acceptance, and in-process product control were found to be inadequate.
Open in Dashboard
ID · f601b967-760d-46df-a62a-d1e632648db5